These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8600306)
41. Dopaminergic innervation of forebrain by ventral mesencephalon in organotypic slice co-cultures: effects of GDNF. Jaumotte JD; Zigmond MJ Brain Res Mol Brain Res; 2005 Mar; 134(1):139-46. PubMed ID: 15790537 [TBL] [Abstract][Full Text] [Related]
42. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease. Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923 [TBL] [Abstract][Full Text] [Related]
43. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Lin LF; Doherty DH; Lile JD; Bektesh S; Collins F Science; 1993 May; 260(5111):1130-2. PubMed ID: 8493557 [TBL] [Abstract][Full Text] [Related]
44. GDNF acutely modulates excitability and A-type K(+) channels in midbrain dopaminergic neurons. Yang F; Feng L; Zheng F; Johnson SW; Du J; Shen L; Wu CP; Lu B Nat Neurosci; 2001 Nov; 4(11):1071-8. PubMed ID: 11593232 [TBL] [Abstract][Full Text] [Related]
45. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon. Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574 [TBL] [Abstract][Full Text] [Related]
46. GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action. Schober A; Peterziel H; von Bartheld CS; Simon H; Krieglstein K; Unsicker K Neurobiol Dis; 2007 Feb; 25(2):378-91. PubMed ID: 17141511 [TBL] [Abstract][Full Text] [Related]
47. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. Hou JG; Lin LF; Mytilineou C J Neurochem; 1996 Jan; 66(1):74-82. PubMed ID: 8522992 [TBL] [Abstract][Full Text] [Related]
48. Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease. Sullivan AM; Opacka-Juffry J; Hötten G; Pohl J; Blunt SB Neurosci Lett; 1997 Sep; 233(2-3):73-6. PubMed ID: 9350835 [TBL] [Abstract][Full Text] [Related]
49. Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. Farkas LM; Dünker N; Roussa E; Unsicker K; Krieglstein K J Neurosci; 2003 Jun; 23(12):5178-86. PubMed ID: 12832542 [TBL] [Abstract][Full Text] [Related]
50. TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons. Poulsen KT; Armanini MP; Klein RD; Hynes MA; Phillips HS; Rosenthal A Neuron; 1994 Nov; 13(5):1245-52. PubMed ID: 7946360 [TBL] [Abstract][Full Text] [Related]
51. The survival response of mesencephalic dopaminergic neurons to the neurotrophins BDNF and NT-4 requires priming with serum: comparison with members of the TGF-beta superfamily and characterization of the serum-free culture system. Krieglstein K; Maysinger D; Unsicker K J Neural Transm Suppl; 1996; 47():247-58. PubMed ID: 8841970 [TBL] [Abstract][Full Text] [Related]
53. Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Storm EE; Huynh TV; Copeland NG; Jenkins NA; Kingsley DM; Lee SJ Nature; 1994 Apr; 368(6472):639-43. PubMed ID: 8145850 [TBL] [Abstract][Full Text] [Related]
54. Cortical astrocytes activated by basic fibroblast growth factor secrete molecules that stimulate differentiation of mesencephalic dopaminergic neurons. Gaul G; Lübbert H Proc Biol Sci; 1992 Jul; 249(1324):57-63. PubMed ID: 1279704 [TBL] [Abstract][Full Text] [Related]
55. Protection of cultured dopamine neurons from MPP(+) requires a combination of neurotrophic factors. Jaumotte JD; Wyrostek SL; Zigmond MJ Eur J Neurosci; 2016 Jul; 44(1):1691-9. PubMed ID: 27098376 [TBL] [Abstract][Full Text] [Related]
56. Cloning and expression of recombinant human growth/differentiation factor 5. Hötten G; Neidhardt H; Jacobowsky B; Pohl J Biochem Biophys Res Commun; 1994 Oct; 204(2):646-52. PubMed ID: 7980526 [TBL] [Abstract][Full Text] [Related]
57. Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons. Rideout HJ; Dietrich P; Savalle M; Dauer WT; Stefanis L J Neurochem; 2003 Feb; 84(4):803-13. PubMed ID: 12562524 [TBL] [Abstract][Full Text] [Related]
58. Midbrain dopaminergic neurons are protected from radical induced damage by GDF-5 application. Short communication. Lingor P; Unsicker K; Krieglstein K J Neural Transm (Vienna); 1999; 106(2):139-44. PubMed ID: 10226934 [TBL] [Abstract][Full Text] [Related]
59. Growth factor function in the development and maintenance of midbrain dopaminergic neurons: concepts, facts and prospects for TGF-beta. Unsicker K; Suter-Crazzalora C; Krieglstein K Ciba Found Symp; 1996; 196():70-80; discussion 80-4. PubMed ID: 8866128 [TBL] [Abstract][Full Text] [Related]